MTCP1 and B-cell chronic lymphocytic leukemia: To interrogate the clinical significance of MTCP1 mRNA expression in CLL, we conducted a retrospective analysis on MTCP1 expression in CLL patients from two independent chemoimmunotherapy trial study cohorts for which microarray data have been previously reported (CALGB ‘9712’ and ‘10101’)27,28.